Variant report
Variant | nsv900744 |
---|---|
Chromosome Location | chr13:86498444-86529275 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188693976 | chr13:86504015-86504016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554338194 | chr13:86504045-86504046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs114697220 | chr13:86504056-86504057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73541867 | chr13:86504091-86504092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530554789 | chr13:86504130-86504131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550189945 | chr13:86504197-86504198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs558156273 | chr13:86504204-86504205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs576676985 | chr13:86504272-86504273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185172548 | chr13:86504294-86504295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190765363 | chr13:86504298-86504299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574179471 | chr13:86504335-86504336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182328065 | chr13:86504345-86504346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs143431747 | chr13:86504349-86504350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs527355571 | chr13:86504351-86504352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs34148434 | chr13:86504370-86504371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs148380999 | chr13:86504402-86504403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs187326655 | chr13:86504438-86504439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs9531890 | chr13:86504474-86504475 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs549856512 | chr13:86504479-86504480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73541869 | chr13:86504536-86504537 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs563222096 | chr13:86504560-86504561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs9547443 | chr13:86504577-86504578 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs143302499 | chr13:86504582-86504583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs147518134 | chr13:86504595-86504596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs67569590 | chr13:86504652-86504653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs138475892 | chr13:86504682-86504683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs375755760 | chr13:86504692-86504693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs35501433 | chr13:86504701-86504702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs75644638 | chr13:86504715-86504716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs111824563 | chr13:86504720-86504721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs191830290 | chr13:86504750-86504751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs574239219 | chr13:86504755-86504756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs541246096 | chr13:86504805-86504806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs9602873 | chr13:86504825-86504826 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs61971088 | chr13:86504831-86504832 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs545531330 | chr13:86504856-86504857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183603394 | chr13:86504859-86504860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540179797 | chr13:86504860-86504861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543392302 | chr13:86504868-86504869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs78370388 | chr13:86504901-86504902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs534994390 | chr13:86504919-86504920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs143936218 | chr13:86504935-86504936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs201763439 | chr13:86504962-86504963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200288738 | chr13:86504968-86504969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs372577938 | chr13:86504969-86504970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs547617355 | chr13:86504971-86504972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs74653810 | chr13:86504972-86504973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs79851067 | chr13:86504973-86504974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs79640310 | chr13:86504974-86504975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185543282 | chr13:86504976-86504977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 19490664 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:86504000-86505000 | Enhancers | Liver | Liver |
2 | chr13:86504200-86504600 | Enhancers | HepG2 | liver |
3 | chr13:86509200-86512400 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr13:86528400-86528800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |